Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jin Zhang
Observed name:
J. Zhang
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
Observed institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
ORCID:
0009-0006-6859-779X
Observed ORCID:
0009-0006-6859-779X
OpenAlex ID:
A5121035224
65MO Neoadjuvant HLX11 versus European Union (EU)-sourced pertuzumab in human epidermal growth factor receptor 2 (HER2)-positive, hormone receptor (HR)-negative early or locally advanced, breast cancer (BC): A double-blind, randomised phase III equivalence study
2025
·
Q. Liu
, Y. Yang
, et al.
·
Annals of Oncology
·
1
Abstract 5236: Updated exploratory biomarker analysis of cadonilimab plus regorafenib as second-line or later therapy in advanced hepatocellular carcinoma: Identification of Bola3 as a potential predictive biomarker
2026
·
Yang Liu
, Jin Zhang
, et al.
·
Cancer Research
Abstract 1051: CXCR4/LITAF as predictive biomarkers for nimotuzumab plus AG therapy in pancreatic cancer with liver metastasis: Integrative single-cell and spatial analysis
2026
·
Linze Xu
, Yang Liu
, et al.
·
Cancer Research
A Prognostic 9-Gene Signature Linked to Autophagy-Dependent Cell Death in Hepatocellular Carcinoma
2026
·
Jin Zhang
, Linze Xu
, et al.
·
Cancer Informatics
921eP Retrospective analysis of driver gene alterations via synchronous DNA and RNA NGS in non-pCR lung adenocarcinoma post neoadjuvant immunotherapy
2025
·
X. Liu
, J. Zhang
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
5
Citation count:
1
H-index:
1
I10-index:
Year
Topic
Type